Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMA vs PRF for Plantar Fasciitis
NCT07242729Recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Modality
- Stem Cell Therapies, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, double-blind trial in plantar fasciitis comparing Bone Marrow Aspirate (BMA) with Platelet-Rich Fibrin (PRF) (2 arms). Primary endpoints: Visual Analog Scale at 24 months and Occurrence of Adverse Events at 24 months. Started Feb 2025; status: recruiting.
02
Drugs
bone marrow aspirateplatelet rich fibrin
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on NCT07242729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07242729.